Shares of Aster DM Healthcare Ltd fell over 3.8% to ₹557.20 in early trade on Tuesday, despite the company posting a strong turnaround in its Q4 FY25 earnings. The stock slipped as much as ₹22.20 from its previous close of ₹579.40, likely due to profit booking after a recent rally.
The healthcare services provider reported a consolidated net profit of ₹79 crore for the March 2025 quarter, a sharp reversal from a net loss of ₹24 crore in the same period last year. The improvement was driven by enhanced operational efficiency and higher revenue contributions.
Revenue from operations for the quarter rose 2.7% YoY to ₹1,000 crore, compared with ₹973.6 crore a year ago. The company’s EBITDA surged 20.5% year-on-year to ₹191.7 crore, up from ₹159.4 crore in Q4 FY24, while the EBITDA margin expanded to 19.2% from 16.4%.
Despite the robust earnings, the stock’s decline may be attributed to short-term investors locking in gains following a recent upward trend, as the scrip had gained notably over the past few weeks.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
